95367 ⎘
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups - in which the condensed system contains three hetero rings Peri-condensed systems
ARYL HYDROCARBON RECEPTOR ACTIVATORS
#2ANTIVIRAL PYRAZOLOPYRIDINONE COMPOUNDS
#3METHODS OF TREATING CENTERAL NERVOUS SYSTEM DISORDERS COMPRISING ADMINISTERING DEUTERATED LUMATEPERONE AND A NITRIC OXIDE DONOR
#4SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS
#5AMORPHOUS SOLID DISPERSIONS
#6ORGANIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE ORGANIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND ELECTRONIC EQUIPMENT INCLUDING THE ELECTRONIC APPARATUS
#7METHODS OF PREPARING ERGOLINE ANALOGS
#8ORGANIC COMPOUNDS
#9TRICYCLIC COMPOUNDS AND USES THEREOF
#10NITROGEN CONTAINING CONDENSED 2,3-DIHYDROQUINAZOLINONE COMPOUNDS AS NAV1.8 INHIBITORS
#11TRICYCLIC DERIVATIVES AND RELATED USES
#12AMORPHOUS SOLID DISPERSIONS
#13ORGANIC COMPOUNDS
#14POLYCYCLIC POLY(ADP-RIBOSE) POLYMERASE SELECTIVE INHIBITOR
#15PI3Ka INHIBITORS
#16COMPOUND AND PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE INCLUDING THE SAME
#17ORGANIC COMPOUNDS
#18PROCESS FOR THE PREPARATION OF 4-((6BR,10AS)-3-METHYL-2,3,6B,9,10,10A-HEXAHYDRO-1H,7H-PYRIDO[3',4':4,5]PYRROLO[1,2,3-DE]QUINOXALIN-8-YL)-1-(4-FLUORO-PHENYL)-BUTAN-1-ONE AND INTERMEDIATES THEREOF
#19ORGANIC COMPOUNDS
#20NON-AROMATIC CYCLIC-PYRIMIDINE ANALOGS AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
#21WNT PATHWAY INHIBITOR COMPOUNDS
#22MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE (PKMYT1) INHIBITORS AND USES THEREOF
#23COMPOUNDS FOR LABELLING NUCLEIC ACID AND USES THEREOF
#24PROCESS FOR PREPARING INTERMEDIATES FOR 1-(4-FLUOROPHENYL)-4-((6bR,10aS)-3-METHYL-2,3,6b,9,10,10a-HEXAHYDRO-1H-PYRIDO[3’,4’:4,5]PYRROLO[1,2,3-de]QUINOXALIN-8(7H)-YL)BUTAN-1-ONE
#25ORGANIC COMPOUND
#26Compounds that Inhibit Necroptosis and Their Preparation Methods
#27TRICYCLIC KINASE INHIBITORS AND USES THEREOF
#28SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS
#29A CLASS OF FUSED RING COMPOUNDS, AND PREPARATION AND USE THEREOF
#30SOLID STATE FORMS OF LUMATEPERONE SALTS AND PROCESSES FOR PREPARATION OF LUMATEPERONE AND SALTS THEREOF
#31NOVEL SALTS AND CRYSTALS
#32SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT
#33NOVEL COMPOUNDS AND METHODS
#34ORGANIC COMPOUNDS
#35SUBSTITUTED HETEROCYCLIC FUSED CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF
#36Amorphous solid dispersions
#37INDOLO[3.2.1-JK]CARBAZOLE-6-CARBONITRILE DERIVATIVES AS BLUE FLUORESCENT EMITTERS FOR USE IN OLEDS
#38TRICYCLIC KINASE INHIBITORS AND USES THEREOF
#39NOVEL PRMT5 INHIBITORS
#40Pharmaceutical compositions comprising heterocycle fused gamma carboline prodrugs
#41AMORPHOUS SOLID DISPERSIONS
#42PROCESS TOWARD THE MANUFACTURE OF (6R,10S)-10-{4-[5-CHLORO-2-(4-CHLORO-1H-1,2,3-TRIAZOL-1-YL)PHENYL]-6-OXO-1(6H)-PYRIMIDINYL}- 1-(DIFLUOROMETHYL)-6-METHYL-1,4,7,8,9,10-HEXAHYDRO-11,15-(METHENO)PYRAZOLO[4,3-B][1,7]DIAZACYCLOTETRADECIN-5(6H)-ONE
#43ORGANIC MOLECULE LIGHT EMITTERS
#44SOLID STATE FORMS OF LUMATEPERONE DITOSYLATE SALT
#45ORGANIC COMPOUNDS, MIXTURES AND APPLICATIONS THEREOF IN ORGANIC ELECTRONIC DEVICES
#46Pharmaceutical compositions comprising 4-((6bR, 10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)butan-1-one for treating central nervous system disorders
#47Method for the production of lumateperone and its salts
#48NOVEL SALTS, CRYSTALS, AND CO-CRYSTALS
#49Pharmaceutical compositions comprising 4-((6bR, 10aS)-3-methyl-2,3,6b,9,10, 10a-hexahydro-1H,7H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)butan-1-ol for treating central nervous system disorders
#50Organic compounds
#51ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT
#52Organic compounds
#53BENZOTHIAZOLYL BIARYL COMPOUND, AND PREPARATION METHOD AND USE
#54CRYSTALLINE FORMS OF GEPOTIDACIN
#55DEGRADER-ANTIBODY CONJUGATES AND METHODS OF USING SAME
#56PRC1 INHIBITORS AND METHODS OF TREATMENT THEREWITH
#57TWO-PHOTON FLUORESCENT PROBE COMPOUND SELECTIVE FOR AMYLOID BETA PLAQUES AND METHOD FOR IMAGING AMYLOID BETA PLAQUES USING SAME
#58Substituted heterocyclic fused cyclic compound, preparation method therefor and pharmaceutical use thereof
#59SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS
#60PERI-CONDENSED HETEROCYCLIC COMPOUNDS AS MATERIALS FOR ELECTRONIC DEVICES
#61Macrocyclic compounds for the treatment of medical disorders
#62PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF
#63Organic compounds
#64NOVEL SALTS AND CRYSTALS
#65NOVEL METHODS
#66ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#67Process for preparing 1-(4-fluorophenyl)-4-((6bR, 10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one
#68Amorphous solid dispersions
#69Lumateperone bis-tosylate salts and crystals and methods for manufacture thereof
#70ARYL HYDROCARBON RECEPTOR ACTIVATORS
#71PAPD5 INHIBITORS AND METHODS OF USE THEREOF
#72Amorphous solid dispersions
#73PRMT5 inhibitors
#74Tricyclic compounds
#75Solid state forms of lumateperone ditosylate salt
#76Substituted heterocycle fused gamma-carbolines synthesis
#77Organic compounds
#78Organic compound
#79SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS
#80SOLID STATE FORMS OF LUMATEPERONE SALTS AND PROCESSES FOR PREPARATION OF LUMATEPERONE AND SALTS THEREOF
#81Compounds and methods
#82Nature-inspired anticancer and antibacterial motifs and pharmaceutical composition thereof
#83Tricyclic heterocycle compounds useful as HIV integrase inhibitors
#84(4-hydroxypyrrolidin-2-yl)-heterocyclic compounds and methods of use thereof
#85MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2
#86COMPOUND AND PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE INCLUDING THE SAME
#87Organic compounds
#88Organic compounds
#89Hole transporting material, method of manufacturing same and organic electroluminescent device
#90TRICYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS
#91Serine/threonine kinase inhibitors
#92TETRACYCLIC BROMODOMAIN INHIBITORS
#93Method for the production of lumateperone and its salts
#94ORGANIC COMPOUNDS
#95FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS
#96Pharmaceutical compositions comprising 4-(6Br,10aS)-3-methyl-2, 3, 6b, 9, 10, 10a-hexahydro-1H, 7H-pyrido[3′, 4′, 5] pyrolo[1,2,3-de] quinoxalin-8YL)-1-(4-fluorophenyl)-butane-1-one and methods of treating conditions of the central nervous system
#97Electrophotographic photoconductor
#98ORGANIC COMPOUNDS
#99ORGANIC COMPOUNDS
#100NOVEL METHODS
#101NOVEL METHODS
#102TETRACYCLIC BROMODOMAIN INHIBITORS
#103Oligomeric perylene diimide non-fullerene acceptors via direct (hetero)arylation cross-coupling reactions
#104Organic compounds
#105Salts and crystals
#106Materials for organic electroluminescent devices
#107ORGANIC LIGHT-EMITTING DEVICE
#108Compounds for use in organic electronic devices
#109Hexacyclic heteroaromatic compounds for electronic devices
#110NOVEL SALTS AND CRYSTALS
#111Solid dispersions of amorphous Lumateperone p-Tosylate
#112Preparation of certain substituted 1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof
#113PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF
#114Pharmaceutical compositions comprising 4-(6BR,10AS)-3-methyl-2,3,6B,9,10,10A-hexahydro-1h, 7H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)butan-1-one and methods of treating conditions of the central nervous system
#115Substituted heterocycle fused gamma-carbolines synthesis
#116NEW ANTIBACTERIAL COMPOUNDS
#117Hydrochloric acid salt of (6bR,10aS)-3-methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxaline
#118Serine/threonine kinase inhibitors
#119Organic light-emitting device and compound
#120Nitrogen-containing heterocycles for use in OLEDs
#121PRC1 inhibitors and methods of treatment therewith
#122Azaphenalene-3-one derivative, preparation method therefor, and application therof
#123Tricyclic heterocycle compounds useful as HIV integrase inhibitors
#124NOVEL CO-CRYSTALS
#125Compositions and methods
#126Organic electroluminescent compound and organic electroluminescent device comprising the same
#127Compositions and methods for making terpenoid indole alkaloids
#128TETRACYCLIC BROMODOMAIN INHIBITORS
#129Amorphous solid dispersions
#130COMPOUND, LIGHT EMITTING MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT
#131Fluorescent pH sensors and methods of preparing them
#132Analogs of vincamine and uses thereof
#133Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
#134Materials for organic light-emitting devices
#135FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS
#136Pharmaceutical compositions comprising ((6bR,10aS)-1-(4-fluorophenyl)-4-(3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one or pharmaceutically acceptable salts thereof
#137Selective inhibitors of gentotoxic steress-induced IKK/NF-κB pathways
#138Antibacterial compounds
#139Analogs of yohimbine and uses thereof
#140Naphthyridinedione derivatives
#141Preparation of certain substituted 1-(4-fluorophenyl)-4-(2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-YL)butan-1-ones and pharmaceutically acceptable salts thereof
#142Solid state forms of lumateperone ditosylate salt
#143Serine/threonine kinase inhibitors
#144Amorphous solid dispersions
#145Organic compounds
#146Antibacterial compounds
#147Aryl hydrocarbon receptor ligands from kynurenine
#148Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3′,4′:4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide
#149Salts and crystals of ITI-007
#150Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl) butan-1-one for inhibiting serotonin reuptake transporter activity
#151Organic compounds
#152Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors
#153Organic compound, electrochromic device, electrochromic apparatus, optical filter, image pickup apparatus, lens unit, and window member
#154TETRACYCLIC BROMODOMAIN INHIBITORS
#155Organic electroluminescent materials and devices
#156PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF
#157Imidazopyrroloquinoline salt, method for producing the same, medicament, cosmetic, and food
#158Compositions and methods for treating mitochondrial diseases
#159FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS
#160Organic electroluminescent materials and devices
#161Organic electroluminescent materials and devices
#162Preparation of certain substituted [((6bR,10aS)-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof
#163Serine/threonine kinase inhibitors
#164Nitrogen annulated perylene diimides for use as electron transport materials in organic electronic devices
#165Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors
#166Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity
#167Triphenylamine derivatives and photovoltaic device including the same
#168FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS
#169Organic compounds
#170Pentacyclic pyridoindolobenzo[b,e]diazepines and thiazepines for treating CNS disorders
#171Organic electroluminescent materials and devices
#172Compounds for electronic devices
#173Tricyclic heterocycle derivatives having HIV replication inhibitory effect
#174Organic electroluminescent compound and organic electroluminescent device comprising the same
#175Organic electroluminescent materials and devices
#176Gyrase inhibitors
#177Organic compounds
#178NEW CYCLAZINES AND THEIR USE AS SEMICONDUCTORS
#179Azatriangulenium salts as PET-quenched fluorescent probes
#180Tricyclic oxazolidinone antibiotic compounds
#181Compositions, uses and methods for their preparation
#182Compositions and methods for treating mitochondrial diseases
#183Organic electroluminescent element
#184Preparation of certain [((6BR,10AS)-2,3,6B,7,8,9,10, 10A-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof
#1854-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de] quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid salt crystal forms
#186Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device
#187Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors
#188Substituted pyrimidinium compounds and derivatives for combating animal pests
#189Crystalline form of N,N-dicyclopropyl-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide for the treatment of myeloproliferative disorders
#190Fused tricyclic heterocyclic compounds as HIV integrase inhibitors
#191Organic electroluminescent materials and devices
#192Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors
#193Substituted benzo[5,6]azepino[3,2,1-hi]pyrido[4,3-b]indoles and substituted benzo[6,7][1,4]oxazepino[2,3,4-hi]pyrido[4,3-b]indoles for treating CNS disorders
#194Substituted pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity
#195Pyridoindolobenz[b,d]azepine derivatives and uses thereof
#196Antibacterial oxadiazolone derivatives
#197Bis-quaternary ammonium cyclophane compounds that interact with neuronal nicotinic acetylcholine receptors
#198Naphthyridinedione derivatives
#199Flindersia alkaloids, derivatives and analogs: compositions and methods for producing the same
#200Materials for organic electroluminescent devices
#201Materials for organic electroluminescent devices
#202Azaindolines
#203Tetracyclic CDK9 kinase inhibitors
#204SPECIFIC INHIBITORS OF PROTEIN P21 AS THERAPEUTIC AGENTS
#205PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF
#206Serine/threonine kinase inhibitors
#207Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors
#208Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders
#209Synthesis of polycyclic alkaloids
#210NOVEL COMPOSITIONS AND METHODS
#211Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders
#212Methods
#213Substituted cycloocta[5,6]pyrido[4,3,2-de]phthalazines as PARP inhibitors
#214Preparation of 4-((6BR,10AS)-3-methyl-2,3,6B,9,10, 10A-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalin-8-(7H)-yl)-1-(4-fluorophenyl)-1-butanone or a pharmaceutically acceptable salt thereof
#215Materials for organic electroluminescent devices
#2164-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid addition salt and salt crystals
#217Organic electroluminescent element, compound for organic electroluminescent element, and light-emitting device, display device, and illumination device using said element
#218Condensed-cyclic compound and organic light-emitting diode comprising the same
#219Bromodomain inhibitors
#220Methods of treating diabetes
#221TRICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF JANUS KINASE
#222Anti-malarial compounds from marine natural products
#223Compound for organic electronic device
#224Tricyclic oxazolidinone antibiotic compounds
#225Materials for organic electroluminescent devices
#226Polymerizable (photosensitive or reactive) cyano-containing compound, a dye, and colored photosensitive composition
#227Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use
#228Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use
#229Pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines derivatives and [1,4]oxazino[2,3,4-hi]pyrido[4,3-b]indole derivatives
#230MATRINIC ACID/MATRINE DERIVATIVES AND PREPARATION METHODS AND USES THEREOF
#231Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK
#232Photoelectric conversion material, film containing the material, photoelectric conversion device, method for preparing photoelectric conversion device, method for using photoelectric conversion device, photosensor and imaging device
#233TRICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF JANUS KINASE
#234Organic electroluminescent devices
#235Substituted 2,3,4,4A,5,9B-hexahydro-1H-pyrido[4,3-B]indole derivatives synthesis and uses thereof
#236Bridged triarylamines and -phosphines as materials for electronic devices
#237Materials for organic electroluminescent devices
#238ORGANIC ELECTROLUMINESCENT DEVICE AND LIGHT-EMITTING POLYMER COMPOSITION
#239Compounds for electronic devices
#240Substituted indoloacridines for organic electroluminescent devices
#241RECYCLABLE CATALYSTS FOR ESTERIFICATION OR ACYLATION OF ALCOHOLS
#242Organic electroluminescence device
#243Bimacrocylic HCV NS3 protease inhibitors
#244Electronic device including phenanthroline derivative
#245Materials for organic electroluminescent devices
#246Compounds, compositions, methods of synthesis, and methods of treatment
#247Tricyclic oxazolidinone antibiotic compounds
#248Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK
#2494-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid addition salt and salt crystals
#250Tricyclic Nitrogen Containing Compounds And Their Use As Antibacterials
#251USE OF CANTHIN-6-ONE AND ITS ANALOGS IN THE TREATMENT OF MYCOBACTERIA-LINKED PATHOLOGIES ( amended
#252Tricyclic derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP)
#253Azatricyclic antibiotic compounds
#254Indazole Compounds for Treating Inflammatory Disorders, Demyelinating Disorders and Cancers
#255Substituted pyrazolo-pyrimidine compounds
#256Pyrimidine compound and medical use thereof
#257-quaternary ammonium cyclophane compounds that interact with neuronal nicotinic acetylcholine receptors
#258Electronic device including phenanthroline derivative
#259HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS
#260Tricyclic anilide spirolactam CGRP receptor antagonists
#261TRICYCLIC COMPOUNDS AS ANTIBACTERIALS
#262Tricyclic nitrogen containing compounds as antibacterial agents
#263Substituted heterocycle gamma-carbolines synthesis
#264Tricyclic heteroaryl compounds useful as inhibitors of Janus kinase
#265Organic electroluminescence device
#266Antiviral compounds
#267Compounds
#268Compounds for organic electronic devices
#269THERAPEUTICALLY USEFUL SUBSTITUTED 1,7-DIPHENYL-1,2,3,5,6,7-HEXAHYDROPYRIDO[3,2,1-Ij]QUINOLINE COMPOUNDS
#270Tryclic nitrogen containing compounds and their use as antibacterials
#271METHODS OF MODULATING NEUROTROPHIN-MEDIATED ACTIVITY
#272BENZOTERRYLENE DERIVATIVES
#273Heterocyclic compounds, their preparation and their use as antibacterials
#274PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF
#275Polymerizable compound, polymer, ink composition, printed articles and inkjet recording method
#276Tricyclic anilide spirolactam CGRP receptor antagonists
#2771,5,6,-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes as anti-inflective agents
#278Compounds for treating inflammatory disorders, demyelinating disdorders and cancers
#279Method for producing organic field-effect transistors
#280Inhibitors Of Akt Activity
#281Crf Receptor Antagonists and Methods Relating Thereto
#282COMPOUNDS
#283Methods of modulating neurotrophin-mediated activity
#284Methods of modulating neurotrophin-mediated activity
#285Methods of modulating neurotrophin-mediated activity
#286Substituted heterocycle fused γ-carbolines
#287Pyrimidine compound and medical use thereof
#288Tetracyclic azepinoindole compounds
#289Substituted pyrido[4′,3′:5,6]pyrazino[1,2-a]indoles as anticancer agents